Meet the Team

telegraph hill partners Rob Capone

Rob

Capone

Partner

Prior to joining THP, Rob most recently worked as a Partner at Trinity Life Sciences, a consultancy focused on evidence-based clinical and commercial development strategy across therapeutics, diagnostics, and medical technology sectors. Rob worked as a strategy consultant for a total of 10 years, partnering with emerging biotechnology & medical technology companies as well as large, global organizations to inform key decisions on clinical development, launch strategy, market development, brand lifecycle strategy, and promotional campaign development. Prior to working as a strategy consultant, Rob worked at Telegraph Hill Partners for four years as an Associate, working on market analysis, transaction execution, and portfolio company initiatives. Prior to working as an Associate at Telegraph Hill Partners, Rob worked as an analyst at Seven Hill Partners, a boutique investment banking firm focused on life sciences and technology verticals. Rob represents THP on the boards of Cell Microsystems and Emerging Therapy Solutions. Rob holds a BBA in Finance from the University of Notre Dame and an MBA with honors from UC Berkeley’s Haas School of Business.